Alexander Kuo

6.2k total citations · 1 hit paper
63 papers, 2.2k citations indexed

About

Alexander Kuo is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Alexander Kuo has authored 63 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Hepatology, 37 papers in Epidemiology and 12 papers in Surgery. Recurrent topics in Alexander Kuo's work include Liver Disease Diagnosis and Treatment (35 papers), Hepatitis C virus research (22 papers) and Liver Disease and Transplantation (14 papers). Alexander Kuo is often cited by papers focused on Liver Disease Diagnosis and Treatment (35 papers), Hepatitis C virus research (22 papers) and Liver Disease and Transplantation (14 papers). Alexander Kuo collaborates with scholars based in United States, Germany and United Kingdom. Alexander Kuo's co-authors include Irine Vodkin, Ju Dong Yang, Walid S. Ayoub, Norah A. Terrault, Yee Hui Yeo, Hirsh D. Trivedi, Aarshi Vipani, Wee Han Ng, Peng–Sheng Ting and Omer Liran and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Alexander Kuo

57 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma

2023 424 citations Yee Hui Yeo, Jamil S. Samaan et al. Clinical and Molecular Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alexander Kuo United States	23	1.4k	1.3k	414	349	332	63	2.2k
Walid S. Ayoub United States	21	992 0.7×	1.1k 0.9×	388 0.9×	350 1.0×	183 0.6×	65	2.0k
Hirsh D. Trivedi United States	16	344 0.2×	456 0.4×	298 0.7×	349 1.0×	173 0.5×	67	1.2k
Danièle Sommacale France	20	1.2k 0.9×	523 0.4×	1.0k 2.5×	26 0.1×	332 1.0×	89	2.1k
Victoria Chernyak United States	30	1.9k 1.4×	1.3k 1.1×	1.0k 2.5×	33 0.1×	1.2k 3.7×	148	3.6k
Mishal Mendiratta‐Lala United States	23	1.2k 0.9×	702 0.6×	440 1.1×	27 0.1×	764 2.3×	92	2.3k
Jean Jeudy United States	30	61 0.0×	310 0.2×	497 1.2×	280 0.8×	1.1k 3.4×	127	2.8k
Tram T. Tran United States	24	1.5k 1.1×	1.7k 1.4×	371 0.9×	13 0.0×	20 0.1×	84	2.5k
Seth Kligerman United States	30	152 0.1×	469 0.4×	503 1.2×	65 0.2×	1.5k 4.4×	113	3.5k
Marc L. Melcher United States	26	305 0.2×	346 0.3×	652 1.6×	7 0.0×	78 0.2×	102	1.9k
Simon Knight United Kingdom	30	428 0.3×	385 0.3×	1.3k 3.2×	17 0.0×	318 1.0×	118	3.0k

Countries citing papers authored by Alexander Kuo

Since Specialization

Citations

This map shows the geographic impact of Alexander Kuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Kuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Kuo more than expected).

Fields of papers citing papers by Alexander Kuo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Kuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Kuo. The network helps show where Alexander Kuo may publish in the future.

Co-authorship network of co-authors of Alexander Kuo

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Kuo. A scholar is included among the top collaborators of Alexander Kuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Kuo. Alexander Kuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ahn, Joseph, Wee Han Ng, Yee Hui Yeo, et al.. (2025). Comparative effectiveness of immunotherapy versus lenvatinib in advanced hepatocellular carcinoma: A real-world analysis using target trial emulation. Hepatology. 83(2). 249–260. 3 indexed citations

Chen, Pin‐Jung, Alexander Kuo, Walid S. Ayoub, et al.. (2025). Clinical outcome after complete response with immunotherapy in hepatocellular carcinoma.. Journal of Clinical Oncology. 43(4_suppl). 573–573.

Yeo, Yee Hui, Itai Danovitch, Karen Chan Osilla, et al.. (2024). The Feasibility and Usability of an Artificial Intelligence-Enabled Conversational Agent in Virtual Reality for Patients with Alcohol-Associated Cirrhosis: A Multi-Methods Study. 1(1). 257–270. 2 indexed citations

Niezen, Sebastian, Aarshi Vipani, Ju Dong Yang, et al.. (2024). Food Insecurity in Hispanic Populations Is Associated with an Increased Risk of Hepatic Steatosis: A Nationally Representative Study. Journal of Clinical Medicine. 13(11). 3206–3206. 2 indexed citations

Samaan, Jamil S., Yee Hui Yeo, Wee Han Ng, et al.. (2023). ChatGPT’s ability to comprehend and answer cirrhosis related questions in Arabic. Arab Journal of Gastroenterology. 24(3). 145–148. 20 indexed citations

Yeo, Yee Hui, Jamil S. Samaan, Wee Han Ng, et al.. (2023). Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma. Clinical and Molecular Hepatology. 29(3). 721–732. 424 indexed citations breakdown →

Yeo, Yee Hui, Michael Luu, Walid S. Ayoub, et al.. (2023). COVID-19 Pandemic Impact on Diagnosis, Stage, and Treatment of Hepatocellular Carcinoma in the United States. SHILAP Revista de lepidopterología. 3(2). 230–237. 2 indexed citations

Rushakoff, Joshua A., Alexander Kuo, Patrick Botting, et al.. (2023). Utility of a score-based approach to liver assessment in heart transplant candidates. SHILAP Revista de lepidopterología. 4. 100045–100045.

Lauzon, Marie, Michael Luu, Joseph Ahn, et al.. (2021). Comparison of Surgical Resection and Systemic Treatment for Hepatocellular Carcinoma with Vascular Invasion: National Cancer Database Analysis. Liver Cancer. 10(5). 407–418. 28 indexed citations

10.

Kuo, Alexander, et al.. (2018). Characteristics and Outcomes Reported by Patients With Primary Sclerosing Cholangitis Through an Online Registry. Clinical Gastroenterology and Hepatology. 17(7). 1372–1378. 21 indexed citations

11.

Lim, Joseph K., Mitchell L. Shiffman, Anna S. Lok, et al.. (2018). Safety and Effectiveness of Ledipasvir and Sofosbuvir, With or Without Ribavirin, in Treatment-Experienced Patients With Genotype 1 Hepatitis C Virus Infection and Cirrhosis. Clinical Gastroenterology and Hepatology. 16(11). 1811–1819.e4. 13 indexed citations

12.

Welzel, Tania M., David R. Nelson, Giuseppe Morelli, et al.. (2016). Effectiveness and safety of sofosbuvir plus ribavirin for the treatment of HCV genotype 2 infection: results of the real-world, clinical practice HCV-TARGET study. Gut. 66(10). 1844–1852. 61 indexed citations

13.

Kuo, Alexander & Christopher L. Bowlus. (2016). Management of symptom complexes in primary biliary cholangitis. Current Opinion in Gastroenterology. 32(3). 1–1. 9 indexed citations

14.

Brown, Robert S., Jacqueline G. O’Leary, K. Rajender Reddy, et al.. (2015). Interferon‐free therapy for genotype 1 hepatitis C in liver transplant recipients: Real‐world experience from the hepatitis C therapeutic registry and research network. Liver Transplantation. 22(1). 24–33. 84 indexed citations

15.

Halldorson, Jeffrey B., Zoheb B. Kazi, Kristin L. Mekeel, et al.. (2015). Successful combined liver/kidney transplantation from a donor with Pompe disease. Molecular Genetics and Metabolism. 115(4). 141–144. 1 indexed citations

16.

Mendler, Michel, Robert G. Gish, Rohit Loomba, et al.. (2014). Hepatocellular Carcinoma Surveillance: A National Survey of Current Practices in the USA. Digestive Diseases and Sciences. 59(12). 3073–3077. 24 indexed citations

17.

Kuo, Alexander & Robert G. Gish. (2012). Chronic Hepatitis B Infection. Clinics in Liver Disease. 16(2). 347–369. 54 indexed citations

18.

Kuo, Alexander & Norah A. Terrault. (2009). Is recurrent hepatitis C worse with living donors?. Current Opinion in Organ Transplantation. 14(3). 240–244. 4 indexed citations

19.

Kuo, Alexander & Norah A. Terrault. (2006). Management of Hepatitis C in Liver Transplant Recipients. American Journal of Transplantation. 6(3). 449–458. 31 indexed citations

20.

Watanabe, Takuji, et al.. (1997). Unexpectedly low immunocompetence in transplant patients on ketoconazole. Clinical Transplantation. 11(6). 599–603. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact